Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism
Med Page Today
JANUARY 24, 2024
(MedPage Today) -- A 4-month-old with congenital hyperinsulinism responded well to off-label treatment with a breast cancer drug, researchers reported. A newborn presented with severe congenital hyperinsulinism due to homozygous deletion of the.
Let's personalize your content